Menten AI Company
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Investors
Connections from
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Palo Alto, California, United States
Founded Date:
2018-08-24
Investor Type:
info@menten.ai
Last Funding Date:
2020-06-30
Total Funding:
4005000.0
Technology:
['BioTech & HealthTech', 'AI Infrastructure']
Employee Number:
1-10
Investors Number:
6.0
Industry:
Medical BioTech